News on Medial

OneCell Diagnostics raises $16 million in round led by Celesta Capital, others

Economic Times · 6m

OneCell Diagnostics, a startup specializing in AI-powered cancer diagnostics, has raised $16 million in a series A funding round. The funding was led by Celesta Capital and included participation from Tenacity Ventures, Cedars Sinai, Eragon, and Singularity Ventures. OneCell plans to use the funds to expand to the US market with its liquid biopsy test, OncoIndx Alfa, which detects circulating tumor cells for precision diagnosis and treatment of cancer. The funding will also help the company democratize precision oncology by making cancer diagnostic testing more accessible and affordable. OneCell has already tested its technology in India and has partnerships with leading medical institutions.